Authors

• G. Kees Hovingh (ORCID: https://orcid.org/0000-0002-8145-1676)
• Sanjiv J. Shah (ORCID: https://orcid.org/0000-0002-5655-8201)
• Brian Malling (ORCID: https://orcid.org/0000-0002-8570-4327)
• Kenichi Tsujita (ORCID: https://orcid.org/0000-0002-4314-259X)
• Manjunatha Revanna
• Nitasha Sarswat (ORCID: https://orcid.org/0000-0003-0233-7881)
• Michelle Lim-Watson (ORCID: https://orcid.org/0000-0001-7123-2931)
• Marianna Fontana (ORCID: https://orcid.org/0000-0002-9233-9831)
• Mathew S. Maurer (ORCID: https://orcid.org/0000-0001-5400-5008)
• Pablo García‐Pavía (ORCID: https://orcid.org/0000-0002-5470-2257)
• Soumitra Kar
• Arnt V. Kristen (ORCID: https://orcid.org/0000-0001-7657-3700)
• Martha Grogan (ORCID: https://orcid.org/0000-0002-2541-4440)
• Kevin Michael Alexander (ORCID: https://orcid.org/0000-0003-4024-3691)
• Mads D.M. Engelmann

Institutions

• Northwestern University (US)
• Mayo Clinic (US)
• NewYork–Presbyterian Hospital (US)
• Novo Nordisk (Denmark) (DK)
• Heidelberg University (DE)
• Columbia University Irving Medical Center (US)
• The Royal Free Hospital (GB)
• University Hospital Heidelberg (DE)
• University of Illinois Chicago (US)
• University of Chicago (US)
• Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
• Hospital Universitario Puerta de Hierro Majadahonda (ES)
• Novo Nordisk (United States) (US)
• Amyloidosis Foundation (US)
• Mayo Clinic in Arizona (US)
• Stanford Medicine (US)
• Mayo Clinic in Florida (US)
• Novo Nordisk (India) (IN)
• University College London (GB)
• Kumamoto University (JP)
• Stanford University (US)

Publication Details

Journal

Circulation

Published

2025-11-10

DOI

https://doi.org/10.1161/circulationaha.125.077304

Citations

5

Primary Topic

Amyloidosis: Diagnosis, Treatment, Outcomes

Type

article

Field-Weighted Citation Impact

4.03